Anyone in the NYC area interested in (and qualify for) the Vertex 770 Extended Access Program?
Of course they have to make a profit! If I was a stockholder in Vertex, I would ecpect a return on my investment. Having said that, VX770 is only successful because of the physical location of the G551D mutation upon the gene (on top). The work being done on VX866 for D f508 will be that work that will most likely be expandable for other mutations. Its hard but we need to be patient.
<br />
<br />We thought we had a cure in 1989 when the CF Gene was discovered.
<br />
<br />Bill
Of course they have to make a profit! If I was a stockholder in Vertex, I would ecpect a return on my investment. Having said that, VX770 is only successful because of the physical location of the G551D mutation upon the gene (on top). The work being done on VX866 for D f508 will be that work that will most likely be expandable for other mutations. Its hard but we need to be patient.
<br />
<br />We thought we had a cure in 1989 when the CF Gene was discovered.
<br />
<br />Bill